Open to Options Chatbot Intervention for the Improvement of Treatment Decision Making in Patients with Newly Diagnosed Cancer

Status: administratively complete

This clinical trial studies the use of a patient support program called Open to Options (O2O) Chatbot in improving patient-physician communication around cancer treatment decisions in patients with newly diagnosed cancer who are preparing for an upcoming appointment with their cancer physician. O2O is an already existing platform that helps patients prepare a list of questions and concerns, and prioritize to what the patient feels is the most important to communicate with their doctor in their upcoming visit. The Chatbot is an automated, menu-based agent being developed in this study to extend the reach and accessibility of the O2O program via the Chatbot's "virtual coaching". The O2O Chatbot program may help improve patient-centered treatment decision-making.

Inclusion Criteria

Patients with a new cancer diagnosis (for the purposes of this pilot, we are recruiting in colon, breast, and melanoma oncology clinics, having worked with these clinical champions as noted above) * While the Chatbot intervention can be used by patients across cancer types and at different stages of treatment (as long as they are preparing for an appointment), we will conduct this pilot trial of the Chatbot prototype only with patients with a new cancer diagnosis. This will ensure a more specific group for the initial pilot assessment
18 years or older
Able to speak and read English, and willing to electronically consent
Appointment with a Rogel Cancer Center cancer clinician within the next 3 weeks
Patients must have a way to access the internet (includes mobile phone)

Exclusion Criteria

Age < 18 years
Inability to speak or read English
Inability to give informed consent
Recurrent cancer

PRIMARY OBJECTIVES:

I. To assess feasibility and acceptability of the O2O Chatbot and its deployment into clinical practice.

II. To explore the impact of the O2O Chatbot prototype on patient reported appraisal of feeling prepared for an upcoming visit with a cancer specialist.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I (PRE-SURVEY): Patients complete survey and then interact with O2O Chatbot over 45 minutes.

ARM II (POST-SURVEY): Patients interact with O2O Chatbot and then complete survey over 45 minutes.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.

Open to Options Chatbot Intervention for the Improvement of Treatment Decision Making in Patients with Newly Diagnosed Cancer

Description

Eligibility Criteria

Locations & Contacts

Trial Objectives and Outline

Trial Phase & Type

Lead Organization

Trial IDs

Have a question?We're here to help

Which trials are right for you?

Have a question?
We're here to help